Procalcitonin in the early course post pediatric cardiac surgery

Zant, Robert, Stocker, Christian, Schlapbach, Luregn Jan, Mayfield, Sara, Karl, Tom and Schibler, Andreas (2016) Procalcitonin in the early course post pediatric cardiac surgery. Pediatric Critical Care Medicine, 17 7: 624-629. doi:10.1097/PCC.0000000000000751


Author Zant, Robert
Stocker, Christian
Schlapbach, Luregn Jan
Mayfield, Sara
Karl, Tom
Schibler, Andreas
Title Procalcitonin in the early course post pediatric cardiac surgery
Journal name Pediatric Critical Care Medicine   Check publisher's open access policy
ISSN 1947-3893
1529-7535
Publication date 2016-07
Year available 2016
Sub-type Article (original research)
DOI 10.1097/PCC.0000000000000751
Open Access Status Not yet assessed
Volume 17
Issue 7
Start page 624
End page 629
Total pages 6
Place of publication Philadelphia, PA, United States
Publisher Lippincott Williams & Wilkins
Collection year 2017
Language eng
Formatted abstract
Objective: Procalcitonin has emerged as a promising infection marker, but previous reports from small-sized studies suggest nonspecific elevation of procalcitonin after pediatric heart surgery. As procalcitonin is increasingly used as a marker for infection in the PICU, the aim of this study was to identify factors associated with postoperative procalcitonin elevation and to investigate the role of procalcitonin as an early marker of outcome after cardiac surgery.

Design: Prospective observational study.

Setting: Single, tertiary referral PICU.

Patients: Patients aged 0-16 years following cardiac surgery with or without cardiopulmonary bypass.

Interventions: Procalcitonin was measured in all patients at admission to PICU, and on postoperative day 1 and 2. Outcome variables included major adverse event, length of stay in PICU, postoperative renal failure requiring temporary dialysis, duration of mechanical ventilation and duration of inotropic support. A major adverse event was defined as cardiac arrest, need for postoperative extracorporeal life support or death within 3 months of cardiac surgery.

Measurements and Main Results: In 221 included patients who underwent 232 operations, procalcitonin at admission to PICU was significantly associated with mechanical ventilation prior to surgery (p = 0.001), preoperative myocardial dysfunction (p = 0.002), duration of cardiopulmonary bypass (p < 0.001), intraoperative cross-clamp time (p = 0.015), and serum lactate at admission (p < 0.001). Patients suffering a major adverse event and patients with postoperative renal failure had significantly higher procalcitonin levels at admission to PICU (p = 0.04 and 0.01, respectively). Furthermore, procalcitonin levels at admission correlated significantly with the length of stay in the PICU (p = 0.005), time on mechanical ventilation (p = 0.03), and duration of inotropic support (p = 0.02).

Conclusions: Elevated levels of procalcitonin in the early phase after pediatric cardiac surgery are a marker for increased risk for major adverse events and postoperative renal failure and increased postoperative morbidity.
Keyword Cardiac surgery
Cardiopulmonary bypass
Extracorporeal membrane oxygenation
Major adverse event
Pediatric cardiac surgery
Procalcitonin
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status UQ

Document type: Journal Article
Sub-type: Article (original research)
Collections: Mater Research Institute-UQ (MRI-UQ)
HERDC Pre-Audit
Admin Only - School of Medicine
School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 1 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 0 times in Scopus Article
Google Scholar Search Google Scholar
Created: Tue, 28 Jun 2016, 02:28:22 EST by System User on behalf of Learning and Research Services (UQ Library)